A Phase IB study of Durvalumab with or without Tremelimumab and Platinum-Doublet Chemotherapy in Advanced Solid Tumours: Canadian Cancer Trials Group Study IND226

Lung Cancer（2020）

引用 19|浏览109

暂无评分

摘要

•Durvalumab and tremelimumab can be safely given with platinum-doublet chemotherapy.•Tremelimumab and durvalumab exposures did not appear affected by chemotherapy.•Efficacy in NSCLC is comparable to other immunotherapy/chemotherapy trials.

查看译文

关键词

Durvalumab,Tremelimumab,Phase I,Immunotherapy,Lung cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要